Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats

被引：10

作者：

Chintala, MS ^{[1
]}

Chiu, PJS ^{[1
]}

Bernadino, V ^{[1
]}

Tetzloff, GG ^{[1
]}

Tedesco, R ^{[1
]}

Sabin, C ^{[1
]}

Watkins, RW ^{[1
]}

Sybertz, EJ ^{[1
]}

机构：

[1] Schering Plough Corp, Res Inst, CNS CV Biol Res, Kenilworth, NJ 07033 USA

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1998年 / 349卷 / 2-3期

关键词：

platelet aggregation; vascular response; blood pressure; pulmonary microcirculation; (111)indium; labeled platelet; hemodynamics;

D O I：

10.1016/S0014-2999(98)00200-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The hemodynamic and platelet effects of the thrombin receptor activating peptide SFLLRN (TRAP) were evaluated in rats. TRAP failed to aggregate rat platelets in vitro (platelet rich plasma) or in vivo in the pulmonary microcirculation. In contrast, TRAP aggregated washed human platelets. Intravenous injection of TRAP (1 mg/kg) in inactin-anesthetized rats produced a biphasic response in blood pressure characterized by an initial depressor response (-25 +/- 3 mmHg for 15-30 s) followed by a pronounced presser response (50 +/- 7 mmHg for 2-3 min). This increase in blood pressure can be attributed to increases in total peripheral resistance since cardiac output remained unchanged. Further, only the presser responses were observed in pithed rats suggesting a direct effect of TRAP in causing smooth muscle contraction. Consequently, rat platelets differ from human platelets in that they are resistant to TRAP whereas fat vasculature is highly sensitive to TRAP. These observations suggest that while the thrombin receptors on rat vasculature may be similar to those on human platelets, the receptors and/or the coupling mechanisms in rat platelets appear different from human platelets. (C) 1998 Elsevier Science B.V. All rights reserved.

引用

页码：237 / 243

页数：7

共 31 条

[1]

ANTONACCIO MJ, 1993, J PHARMACOL EXP THER, V266, P125

[2]

AWBREY BJ, 1979, J BIOL CHEM, V254, P4092

[3] THROMBIN IMMOBILIZED TO EXTRACELLULAR-MATRIX IS A POTENT MITOGEN FOR VASCULAR SMOOTH-MUSCLE CELLS - NONENZYMATIC MODE OF ACTION [J].

BARSHAVIT, R ;

BENEZRA, M ;

ELDOR, A ;

HYAM, E ;

FENTON, JW ;

WILNER, GD ;

VLODAVSKY, I .

CELL REGULATION, 1990, 1 (06) :453-463

[4] HEMODYNAMIC ACTIONS OF A SYNTHETIC ATRIAL-NATRIURETIC-FACTOR [J].

BAUM, T ;

SYBERTZ, EJ ;

WATKINS, RW ;

NELSON, S ;

COLEMAN, W ;

PULA, KK ;

PRIOLI, N ;

RIVELLI, M ;

GROSSMAN, A .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (05) :898-905

[5] MITOGENIC ACTIVITY OF BLOOD COMPONENTS .1. THROMBIN AND PROTHROMBIN [J].

CHEN, LB ;

BUCHANAN, JM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (01) :131-135

[6]

Chiu P. J. S., 1994, Journal of Biomedical Science, V1, P43

[7]

CHIU PJS, 1997, EUR J PHARMACOL, V321, P463

[8] THROMBIN RECEPTOR ACTIVATING PEPTIDES - IMPORTANCE OF THE N-TERMINAL SERINE AND ITS IONIZATION STATE AS JUDGED BY PH-DEPENDENCE, NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, AND CLEAVAGE BY AMINOPEPTIDASE-M [J].

COLLER, BS ;

WARD, P ;

CERUSO, M ;

SCUDDER, LE ;

SPRINGER, K ;

KUTOK, J ;

PRESTWICH, GD .

BIOCHEMISTRY, 1992, 31 (47) :11713-11720

[9] Role of the thrombin receptor In development and evidence for a second receptor [J].

Connolly, AJ ;

Ishihara, H ;

Kahn, ML ;

Farese, RV ;

Coughlin, SR .

NATURE, 1996, 381 (6582) :516-519

[10]

CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627

← 1 2 3 4 →